Unless the context otherwise requires, the following definitions govern the construction of this chapter:
(a)“Adverse event” means an event in which an animal is injured, sickened, rendered unconscious, or killed.
(b)“Animal” includes, but is not limited to, any domesticated fowl or nonhuman mammal or any wild fowl, bird, or mammal that is reduced to captivity.
(c)“Biologics” means all viruses, serums, antibody products, toxins (excluding substances that are selectively toxic to microorganisms, such as antibiotics), or analogous products at any stage of production, shipment, distribution, or sale, which are intended
for use in the treatment of animals and that act primarily through the direct stimulation, supplementation, enhancement, or modulation of the immune system or immune r
Free access — add to your briefcase to read the full text and ask questions with AI
Unless the context otherwise requires, the following definitions govern the construction of this chapter:
(a)
“Adverse event” means an event in which an animal is injured, sickened, rendered unconscious, or killed.
(b)
“Animal” includes, but is not limited to, any domesticated fowl or nonhuman mammal or any wild fowl, bird, or mammal that is reduced to captivity.
(c)
“Biologics” means all viruses, serums, antibody products, toxins (excluding substances that are selectively toxic to microorganisms, such as antibiotics), or analogous products at any stage of production, shipment, distribution, or sale, which are intended
for use in the treatment of animals and that act primarily through the direct stimulation, supplementation, enhancement, or modulation of the immune system or immune response.
(d)
“Blood and blood component products” means whole blood collected directly from a donor animal for transfusion or the blood components for transfusion, including packed red blood cells, platelet-rich plasma, platelet concentrates, fresh plasma, fresh frozen plasma, frozen plasma, cryoprecipitate, and cryosupernatant. Antibody products like hyperimmune serums are considered “biologics” and are excluded from this definition of blood and blood component products.
(e)
“Captive closed colony” has the same meaning as in Section 4920 of the Business and Professions Code and means that an animal is kept, housed, or maintained in any way for the purpose of collecting its blood.
(f)
“Closed-colony blood bank” has the same meaning as in Section 4920 of the Business and Professions Code and means a commercial blood bank for animals that produces animal blood or blood component products solely from animals held in a captive closed colony.
(g)
“Commercial blood bank for animals” has the same meaning as in Section 4920 of the Business and Professions Code and means an establishment that produces animal blood or blood component products from captive closed-colony or community-sourced animals to market and sell for use in the cure, mitigation, treatment, or prevention of injury or disease in animals.
(h)
“Community blood bank” has the same meaning as in Section 4920 of the Business and Professions Code and means a commercial blood bank for animals that produces animal blood or blood component products
solely from community-sourced animals whose owners voluntarily consent to the donation.
(i)
“Community sourced” has the same meaning as in Section 4920 of the Business and Professions Code and means that an animal is all of the following:
(1)
Kept, housed, and maintained at the residence of its owner who is a person and not a partnership, association, corporation, or limited liability company.
(2)
Brought by its owner to a community blood bank to have its blood collected.
(3)
Licensed in accordance with any pet licensing required by the pet owner’s state, county, or city of residence.
(j)
“Production” has the same meaning as in Section 4920 of the Business and Professions Code and means
collection of blood or the preparation, testing, processing, storage, or distribution of blood or blood component products for the purpose of transfusion.